business strategy
publication date
Strategy
FTC Chief Gears Up for a Showdown With Private Equity
Over the past three years, regulators have signaled they would apply more scrutiny to private equity acquisitions in healthcare.
Technology
Using RTLS Tech to Improve Workflows, Patient Care
Aurora Health Care has integrated the technology into new clinics, giving providers and patients a pathway to better care coordination
Finance
2 Financial Strategies the CFO of McLaren Will Prioritize in 2024
Two major strategies are at the forefront of one CFO's 2024 financial planning.
Finance
Why One CFO Is Betting on Rev Cycle in 2024
To beat payers at their own game, one CFO is looking to his revenue cycle to even the playing field.
Strategy
FTC Cracks Down on M&A, Blocks John Muir Health's Deal With Tenet
The move comes after the agency indicated it may intervene in more acquisitions going forward.
Post-Acute
Why Long-Term Care Insurance Falls Short for So Many
For decades, the industry severely underestimated how many policyholders would use their coverage.
Marketing
Perspective: From Hospital to Hospitality -- Spin Doctors Brand Getting Sick as an Adventure. It's Not.
On these journeys, you don't get to go anywhere ? except maybe the hospital or doctor's office.
Revenue Cycle
Out for Blood? For Routine Lab Work, the Hospital Billed Her $2,400
The hospital charged $9,520.02 for the blood tests and pathology services. The insurer paid $4,310.38, leaving the patient with a...
Extra Fees Drive Assisted Living Profits
Highly profitable facilities often charge $5,000 a month or more and then layer on fees at every step.
Strategy
HCA Pushes for Aggressive Market Share Expansion
The health system titan outlined its plans to continue growing during its first investor day in 20 years.
Payer
The Exec: Oscar Health CIO Alessa Quane Scopes the ACA Marketplace
The executive identifies pivotal strategies and trends for 2024 and beyond.
Pharma
Biden Administration's Limit on Drug Industry Middlemen Backfires, Pharmacists Say
PBMs are loathed by independent drugstores, drugmakers, and patients alike, who accuse them of siphoning money without providing additional value.